• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Eliminate the 2.3 percent med-tech excise tax, urges Congresswoman Cathy McMorris Rodgers (R-Wash.) at Jobs & Innovation Forum | MassDevice.com On Call

Eliminate the 2.3 percent med-tech excise tax, urges Congresswoman Cathy McMorris Rodgers (R-Wash.) at Jobs & Innovation Forum | MassDevice.com On Call

September 22, 2011 By MassDevice staff

MassDevice On Call

MASSDEVICE ON CALL — Congresswoman Cathy McMorris Rodgers (R-Wash.) urged fellow Republicans to push for the repeal of the 2.3 percent medical device excise tax set to go into effect in 2013 during the first Jobs & Innovation Forum this week.

Rodgers called the FDA’s device review process "onerous and inconsistent," calling for fewer unnecessary regulations on med-tech to spur innovation and job-creation.

"American engineers and developers are wary of getting involved with the FDA and are increasingly taking their business overseas first, because they know their product is likely to be active in foreign markets for years before it has a chance of being accessed in the U.S.," Rodgers warned in an editorial published by Healthwatch.

Rodgers, a fourth-term Congresswoman and member of the House Energy & Commerce Committee, hosted the forum, which featured a roundtable discussion with House Republicans and medical device companies.

Dialysis 3 times a week isn’t enough, federal study says

A three-times-per-week dialysis regimen leaves a two-day gap that may put diabetics and others with kidney failure at increased risk of death, heart attack or hospitalization, the Associated Press reported.

Blood test may diagnose heart attacks

A blood test identifying a large protein known as cardiac myosin binding protein-C, which researchers say is released after a heart attack, may be able to give physicians better insight into diagnosis, according to a press release.

New institute launches to find out why the U.S. spends so much on health care

The Health Care Cost Institute aims to gain access to unprecedented amounts of health care cost and utilization data to figure out where all the billions spent on health care in the U.S. are going, Healthwatch reported.

Implantable LED prostate cancer detector

Korean researchers developed a new type of flexible, bio-compatible LED biosensor that can detect prostate cancer from the inside, according to a press release.

Filed Under: Diagnostics, News Well, Oncology

More recent news

  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year
  • Axoft makes Fleuron BCI material available for purchase, inks license deal with Stanford
  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy